Yujun DONG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy (NCT07012304) | Yujun DONG | 2025-06-30 |
Track Yujun DONG automatically
Every clearance here is in the API, with alerts when new ones post.